153 related articles for article (PubMed ID: 38644278)
1. [Clinical significance of immune checkpoint inhibitors in neoadjuvant therapy for gastric cancer].
Zhu ZG
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1331-1336. PubMed ID: 38644278
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of immunotherapy plus chemotherapy as neoadjuvant treatment for patients with locally advanced gastric cancer: a retrospective cohort study.
Wang X; Huang J; Huang H; Liu Y; Ji C; Liu J
Invest New Drugs; 2023 Aug; 41(4):579-586. PubMed ID: 37368088
[TBL] [Abstract][Full Text] [Related]
3. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
[TBL] [Abstract][Full Text] [Related]
4. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
5. Application of immune checkpoint inhibitors in immunotherapy for gastric cancer.
Wu YX; Zhou XY; Wang JQ; Chen GM; Chen JX; Wang RC; Huang JQ; Chen JS
Immunotherapy; 2023 Feb; 15(2):101-115. PubMed ID: 36597704
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant treatment for locally advanced gastric cancer].
Zhao LL; Zhao DB; Chen YT
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):907-911. PubMed ID: 33256300
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
Zhang Z; Cheng S; Gong J; Lu M; Zhou J; Zhang X; Li J; Shen L; Peng Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e33-e39. PubMed ID: 32732092
[TBL] [Abstract][Full Text] [Related]
8. Pathologic Complete Response After Gastric Artery Chemoembolization Combined With Tislelizumab for Neoadjuvant Therapy of Locally Advanced Gastric Cancer: A Case Report.
Lin Y; Chen Y; Lin S; Zheng J; Zhang X; Gan L
J Immunother; 2024 Apr; 47(3):101-105. PubMed ID: 38037229
[TBL] [Abstract][Full Text] [Related]
9. Advances in clinical immunotherapy for gastric cancer.
Li K; Zhang A; Li X; Zhang H; Zhao L
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188615. PubMed ID: 34403771
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer.
Li S; Yu W; Xie F; Luo H; Liu Z; Lv W; Shi D; Yu D; Gao P; Chen C; Wei M; Zhou W; Wang J; Zhao Z; Dai X; Xu Q; Zhang X; Huang M; Huang K; Wang J; Li J; Sheng L; Liu L
Nat Commun; 2023 Jan; 14(1):8. PubMed ID: 36596787
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
Li S; Xu Q; Dai X; Zhang X; Huang M; Huang K; Shi D; Wang J; Liu L
Ann Surg Oncol; 2023 Jun; 30(6):3594-3602. PubMed ID: 36795255
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy-Based Neoadjuvant Treatment of Advanced Microsatellite Instability-High Gastric Cancer: A Case Series.
Liu L; Woo Y; D'Apuzzo M; Melstrom L; Raoof M; Liang Y; Afkhami M; Hamilton SR; Chao J
J Natl Compr Canc Netw; 2022 Aug; 20(8):857-865. PubMed ID: 35948034
[TBL] [Abstract][Full Text] [Related]
13. Immunoneoadjuvant therapy with immune checkpoint inhibitors of gastric cancer: an emerging exemplification : Immunoneoadjuvant therapy of gastric cancer.
Yao G; Yuan J; Duan Q; Tan Y; Zhang Q; Chen D; Chen J
Invest New Drugs; 2024 Feb; 42(1):1-13. PubMed ID: 37971628
[TBL] [Abstract][Full Text] [Related]
14. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
15. Sintilimab plus fluorouracil, leucovorin, oxaliplatin and docetaxel regimen as neoadjuvant therapy for resectable gastric cancer and biomarker exploration.
Wei J; Guo X; Yang X; Liu J; Duan Q; Tan Y; Zhang Q; Sun T; Qi C; Li X; Ji G
Future Oncol; 2023 Nov; 19(36):2395-2403. PubMed ID: 37990937
[TBL] [Abstract][Full Text] [Related]
16. Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching.
Jing SW; Zhai C; Zhang W; He M; Liu QY; Yao JF; Wang R; Tian ZQ; Wang J; Liu JF
Front Immunol; 2022; 13():970534. PubMed ID: 36275724
[TBL] [Abstract][Full Text] [Related]
17. [Surgical management of gastric cancer in the era of immunotherapy].
Li ZY; Jia YN; Lu XX; Guan GM; Wang Q
Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):353-358. PubMed ID: 38548601
[TBL] [Abstract][Full Text] [Related]
18. Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study.
Su P; Jiang L; Zhang Y; Yu T; Huang H; Chen M; Cao C; Kang W; Liu Y; Yu J
Eur J Med Res; 2023 Oct; 28(1):409. PubMed ID: 37814327
[TBL] [Abstract][Full Text] [Related]
19. Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer.
Zeng Z; Yang B; Liao Z
Future Oncol; 2021 Apr; 17(12):1553-1569. PubMed ID: 33397136
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer: A Randomized, Controlled Study.
Ma J; Yao S; Li XS; Kang HR; Yao FF; Du N
Medicine (Baltimore); 2015 Oct; 94(42):e1489. PubMed ID: 26496252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]